Report #2831330

Overview

Sex

Female

Age

Age unknown

State

—

Recovered

Unknown

Vaccinated

—

Onset

—

Days to onset

—

Hospital days

—

Symptoms (1)

Symptom narrative

second dose after a year; This non-serious case was reported by a consumer via interactive digital media and described the occurrence of drug dose administration interval too long in a 3-year-old female patient who received Men B NVS (Bexsero) for prophylaxis. Previously administered products included Bexsero (received first dose of Bexsero at 7 months). On an unknown date, the patient received the 2nd dose of Bexsero. On an unknown date, an unknown time after receiving Bexsero, the patient experienced drug dose administration interval too long (Verbatim: second dose after a year). The outcome of the drug dose administration interval too long was not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 05-MAR-2025 The case was received from the patient via (Bexsero GSK Chatbot) interactive digital media. The reporter had a patient who received first dose of Bexsero at 7 months and the second dose after a year. At the time of reporting the patient had 3 years and 10 months. The reporter asked was she safe, should she get another dose. The patient received second dose of Bexsero longer than the recommended interval which led to lengthening of vaccination schedule.